Global Influenza Vaccine Market 2018-2022

Publisher Name :
Date: 09-Jan-2018
No. of pages: 113
Inquire Before Buying

Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.

The analysts forecast global influenza vaccine market to grow at a CAGR of 7.23% during the period 2018-2022.

Covered in this report

This report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


This report, Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • AstraZeneca

  • CSL

  • GlaxoSmithKline

  • Sanofi


Other prominent vendors


  • Altimmune

  • BionVax

  • FluGen

  • FOLIA BIOTECH

  • Genentech

  • Green Cross

  • Medicago

  • Moderna Therapeutics

  • Novavax

  • Shijiazhuang Yiling Pharmaceutical

  • SK Chemicals

  • UNM Pharma

  • Vaccitech

  • Vaxart

  • Vaxine Pty

  • Visterra.


Market driver


  • Rising awareness about influenza vaccination

  • For a full, detailed list, view our report


Market trend


  • Development of strong pipeline

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2022 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

Global Influenza Vaccine Market 2018-2022

Table of Contents

PART 01: Executive Summary

PART 02: Scope of The Report

PART 03: Research Methodology

PART 04: Introduction
Market Outline

PART 05: Market Landscape
Market Ecosystem
Market Characteristics
Market Segmentation Analysis

PART 06: Market Sizing
Market Definition
Market Sizing 2017
Market Size and Forecast 2017-2022

PART 07: Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Threat of New Entrants
Threat of Substitutes
Threat of Rivalry
Market Condition

PART 08: Pipeline Landscape

PART 09: Market Segmentation by Vaccine Type
Overview
Comparison by Vaccine Type
Global Live Attenuated Influenza Vaccines Market
Global Recombinant Influenza Vaccines Market
Market Opportunity by Vaccine Type

PART 10: Market Segmentation by Age Group
Adults
Pediatrics

PART 11: Customer Landscape

PART 12: Regional Landscape
Geographical Segmentation
Regional Comparison
Influenza Vaccine Market in Americas
Influenza Vaccine Market in Emea
Influenza Vaccine Market in Apac
Market Opportunity

PART 13: Decision Framework

PART 14: Drivers and Challenges
Market Drivers
Market Challenges

PART 15: Market Trends
Strong Pipeline
Strategic Alliances

PART 16: Vendor Landscape
Overview
Landscape Disruption

PART 17: Vendor Analysis
Overview
Vendor Classification
Market Positioning of Vendors
Astrazeneca
Csl
Glaxosmithkline
Sanofi

PART 18: Appendix
List of Abbreviations

List of Exhibits

Exhibit 01: Parent Market
Exhibit 02: Global Vaccine Market: Segmentation
Exhibit 03: Market Characteristics
Exhibit 04: Market Segments
Exhibit 05: Market Definition: Inclusions and Exclusions Checklist
Exhibit 06: Market Size 2017
Exhibit 07: Validation Techniques Employed For Market Sizing 2017
Exhibit 08: Global Influenza Vaccine Market 2017-2022 ($ Millions)
Exhibit 09: Global Influenza Vaccine Market: Year-Over-Year Growth 2018-2022 (%)
Exhibit 10: Five Forces Analysis 2017
Exhibit 11: Five Forces Analysis 2022
Exhibit 12: Bargaining Power of Buyers
Exhibit 13: Bargaining Power of Suppliers
Exhibit 14: Threat of New Entrants
Exhibit 15: Threat of Substitutes
Exhibit 16: Threat of Rivalry
Exhibit 17: Market Condition: Five Forces 2017
Exhibit 18: Pipeline Landscape by Development Phase
Exhibit 19: Key Clinical Trials Candidates of Influenza Vaccines
Exhibit 20: Global Influenza Vaccine Market by Vaccine Type 2017-2022 (%)
Exhibit 21: Comparison by Vaccine Type
Exhibit 22: Global Live Attenuated Influenza Vaccines Market 2017-2022 ($ Millions)
Exhibit 23: Global Live Attenuated Influenza Vaccines Market: Year-Over-Year Growth 2018-2022 (%)
Exhibit 24: Global Recombinant Influenza Vaccines Market 2017-2022 ($ Millions)
Exhibit 25: Global Recombinant Influenza Vaccines Market: Year-Over-Year Growth 2018-2022 (%)
Exhibit 26: Market Opportunity by Vaccine Type
Exhibit 27: Adult Influenza Vaccine Products and Their Cost
Exhibit 28: Pediatric Influenza Vaccine Products and Their Cost
Exhibit 29: Customer Landscape
Exhibit 30: Global Influenza Vaccine Market by Geography 2017-2022 (%)
Exhibit 31: Regional Comparison
Exhibit 32: Influenza Vaccine Market in Americas 2017-2022 ($ Millions)
Exhibit 33: Influenza Vaccine Market in Americas: Year-Over-Year Growth 2018-2022 (%)
Exhibit 34: Top 3 Countries in Americas
Exhibit 35: Influenza Vaccine Market in Emea 2017-2022 ($ Millions)
Exhibit 36: Influenza Vaccine Market in Emea: Year-Over-Year Growth 2018-2022 (%)
Exhibit 37: Top 3 Countries in Emea
Exhibit 38: Influenza Vaccine Market in Apac 2017-2022 ($ Millions)
Exhibit 39: Influenza Vaccine Market in Apac: Year-Over-Year Growth 2018-2022 (%)
Exhibit 40: Top 3 Countries in Apac
Exhibit 41: Market Opportunity
Exhibit 42: Distribution of Influenza Vaccine Doses in Us by Season
Exhibit 43: Steps For Production of Iiv
Exhibit 44: Molecules in Phase Iii With Sponsors
Exhibit 45: Vendor Landscape
Exhibit 46: Landscape Disruption
Exhibit 47: Vendor Landscape
Exhibit 48: Vendor Classification
Exhibit 49: Market Positioning of Vendors
Exhibit 50: Astrazeneca: Overview
Exhibit 51: Astrazeneca: Business Segments
Exhibit 52: Astrazeneca: Organizational Developments
Exhibit 53: Astrazeneca: Geographic Focus
Exhibit 54: Astrazeneca: Segment Focus
Exhibit 55: Astrazeneca: Key Offerings
Exhibit 56: Astrazeneca: Key Customers
Exhibit 57: Csl: Overview
Exhibit 58: Csl: Business Segments
Exhibit 59: Csl: Organizational Developments
Exhibit 60: Csl: Geographic Focus
Exhibit 61: Csl: Segment Focus
Exhibit 62: Csl: Key Offerings
Exhibit 63: Csl: Key Customers
Exhibit 64: Glaxosmithkline: Overview
Exhibit 65: Glaxosmithkline: Business Segments
Exhibit 66: Glaxosmithkline: Organizational Developments
Exhibit 67: Glaxosmithkline: Geographic Focus
Exhibit 68: Glaxosmithkline: Segment Focus
Exhibit 69: Glaxosmithkline: Key Offerings
Exhibit 70: Glaxosmithkline: Key Customers
Exhibit 71: Sanofi: Overview
Exhibit 72: Sanofi: Business Segments
Exhibit 73: Sanofi: Organizational Developments
Exhibit 74: Sanofi: Geographic Focus
Exhibit 75: Sanofi: Segment Focus
Exhibit 76: Sanofi: Key Offerings
Exhibit 77: Sanofi: Key Customers

  • Global Meningococcal Vaccines Market Professional Survey Report 2017
    Published: 26-Dec-2017        Price: US 3500 Onwards        Pages: 108
    This report studies Meningococcal Vaccines in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - GlaxoSmithKline - JN-International Medical - Novartis International......
  • Global Avian Influenza Vaccines Market Professional Survey Report 2017
    Published: 14-Dec-2017        Price: US 3500 Onwards        Pages: 119
    This report studies Avian Influenza Vaccines in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Merial - QYH Biotech - DHN - HVRI - CEVA - El......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Professional Survey Report 2017
    Published: 14-Dec-2017        Price: US 3500 Onwards        Pages: 109
    This report studies 23-Valent Pneumococcal Polysaccharide Vaccine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - MSD - Sanofipasteur - CDIBP On......
  • 2015-2023 World Avian Influenza Vaccines Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 13-Dec-2017        Price: US 2800 Onwards        Pages: 159
    Summary Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred. This report includes market status and forecast of global and major regions, with i......
  • Global Encephalitis Vaccination Market Professional Survey Report 2017
    Published: 06-Dec-2017        Price: US 3500 Onwards        Pages: 115
    This report studies Encephalitis Vaccination in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Beijing Tiantan - Lanzhou Institute of Biological - CHENGDU INSTIT......
  • United States Meningococcal Vaccines Market Report 2017
    Published: 05-Dec-2017        Price: US 3800 Onwards        Pages: 101
    In this report, the United States Meningococcal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth r......
  • Global Meningococcal Vaccines Sales Market Report 2017
    Published: 30-Nov-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Meningococcal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Meningococcal Vaccines for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • United States Avian Influenza Vaccines Market Report 2017
    Published: 23-Nov-2017        Price: US 3800 Onwards        Pages: 112
    In this report, the United States Avian Influenza Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth......
  • United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2017
    Published: 23-Nov-2017        Price: US 3800 Onwards        Pages: 96
    In this report, the United States 23-Valent Pneumococcal Polysaccharide Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs